Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 304
Selected: 0
NCT IDTitle
NCT01331525The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer
NCT00664781Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer
NCT01805375A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies
NCT00004209Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
NCT07432932Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients
NCT01598792Safety Study of Recombinant Listeria Monocytogenes(Lm)Based Vaccine Virus Vaccine to Treat Oropharyngeal Cancer
NCT01737255Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome
NCT04307576A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
NCT01791985AZD4547 & Anastrozole or Letrozole (NSAIs) in ER+ Breast Cancer Patients Who Have Progressed on NSAIs (RADICAL)
NCT06714630The PROSECCA Study, Answering New Questions in Prostate Cancer
NCT00554775WBRT & Erlotinib in Advanced NSCLC and Brain Metastases
NCT03212157GlucoCEST MRI in Oncology
NCT00814567Radiation Therapy in Women With Low Risk Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery
NCT03307746A Combination of Rituximab and Varlilumab Immunotherapy in Patients with B-cell Lymphoma
NCT05722886DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol
NCT02170090Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer
NCT03024580A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer
NCT03756597PAN-study: Pan-Cancer Early Detection Study (PAN)
NCT01279967A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma
NCT00896818Genes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and Friends
NCT05770037DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers
NCT06289374Longitudinal Assessment of Biomarkers After Oesophagogastric Cancer Surgery
NCT03705507International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia
NCT00801736ERCC1 Targeted Trial
NCT00275132Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
NCT02544308Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma
NCT01719835CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study
NCT03371485AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer
NCT00863733Study of DMXAA (Now Known as ASA404) in Solid Tumors
NCT01862003Phase I/II Trial of Antagonism of HER in GI Cancer
NCT00261456The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer
NCT02866370Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium
NCT02530411Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast Cancer
NCT02121639Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP Chemotherapy
NCT03145961A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients
NCT00977210Safety Study of OXi4503 (a Vascular Disrupting Agent) Given by 3 x Weekly Intravenous Infusions to Patients With Advanced Solid Tumors
NCT00002476Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
NCT0010489717-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma
NCT03548688Investigation and Detection of Urological Neoplasia in Patients Referred With Suspected Urinary Tract Cancer:
NCT02664935National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer
NCT00433563Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung Cancer
NCT05272709TT-702 in Patients With Advanced Solid Tumours.
NCT00748527Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NCT01390571Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma
NCT00757211Study of Genes and Environment in Patients With Breast Cancer in the East Anglia Region of the United Kingdom
NCT04226937DLBCL Interim Response Evaluation for Customised Therapy
NCT03245177Pembrolizumab in Combination With Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
NCT01324115NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors
NCT02583542A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers
NCT04063566ReIMAGINE Prostate Cancer Screening